Neurofilament Light Chain As A Biomarker For Chemotherapy-Induced Peripheral Neuropathy

Thanks for your interest in our webinar hosted in partnership with Nature Research! Unlock immediate access to the full recording by filling out the form.

 

What you’ll learn:

  • Can neurofilament light chain be used as an objective biomarker for chemotherapy-induced neurotoxicity in vitro?
  • Will neurofilament light chain be a biomarker for all types of chemotherapy-induced peripheral neuropathy?
  • What is the diagnostic and prognostic value of neurofilament light chain as a biomarker for chemotherapy-induced peripheral neuropathy

Complete the form and start watching now!


Speaker:
Tore B. Stage
Head of Research at Clinical Pharmacology, Pharmacy and Environmental Medicine University of Southern Denmark

By submitting the form you agree to Quanterix’s Terms and Conditions.  If you have subscribed to our email marketing you can unsubscribe at any time, and you can learn more about how we manage your personal details in our Privacy Policy.